(Q28272556)

2

0 references

H House

3

0 references

C Bateman

4

0 references

P Robson

Multiple Sclerosis Journal

5

0 references

language of work or name

English

0 references

publication date

October 2006

0 references

published in

0 references

volume

12

0 references

issue

5

0 references

page(s)

639-45

0 references

cites work

The perceived effects of smoked cannabis on patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458505070618

Safety, tolerability, and efficacy of orally administered cannabinoids in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458505070618

A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458505070618

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458505070618

Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458505070618

Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458505070618

An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458505070618

Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458505070618

Cognitive functioning of long-term heavy cannabis users seeking treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458505070618

Causal association between cannabis and psychosis: examination of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458505070618

Psychiatric effects of cannabis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458505070618

Cannabis and Cannabis Extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458505070618

The Barthel ADL Index: a reliability study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458505070618

The Guy's Neurological Disability Scale in patients with multiple sclerosis: a clinical evaluation of its reliability and validity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458505070618